“Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s17, https://doi.org/10.25251/skin.5.supp.17.